Neutrophil extracellular traps in atherosclerosis: current evidence and therapeutic potential of plant-derived metabolites.

Front Pharmacol · 2026 · PMC13226601 · PMID 42239510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Under strictly controlled in vitro conditions, a compound may cause a nominally significant reduction in cfDNA, MPO-DNA, H3Cit, or ROS levels.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.